16 November 2021: The board of directors of Observe Medical ASA (the "Company") has resolved to grant 120,000 share options in the Company to the group CFO, Per Arne Nygård. Per Arne Nygård was engaged as interim CFO of the group as an consultant on 10 December 2019, and was permanently employed as CFO of…
Oslo, November, 3rd, 2021 – Observe Medical ASA (OSE: OBSRV) today released its financial results and presentation of the third quarter of 2021. The Company reports strong revenue growth for the Nordic portfolio, continued progress in the commercialization and go-to-market execution for Sippi® including an update on preparations for US market entry. CEO of Observe Medical,…
Observe Medical ASA invites you to a presentation of the third quarter 2021. The presentation will take place at Felix Konferansesenter in Oslo on Wednesday, November 3rd. The event will start at 08.30 CET and will be webcasted live on www.observemedical.com – Investor relations and at the following link: https://channel.royalcast.com/landingpage/hegnarmedia/20211103_5/ Representatives from the Company will…
Oslo, October 22, 2021 – Observe Medical ASA (OSE: OBSRV) continues its rollout of Sippi®, and reports clinical implementation at several sites in Europe – including use outside intensive care units, and clinical evaluations driving the health economic value of Sippi® “We are excited to see Sippi® implementation gaining momentum as society and hospitals now…
FINANCIAL YEAR 2021 03.11.2021 – Quarterly Presentation – Q3 17.02.2022 – Quarterly Presentation – Q4 29.04.2022 – Annual Report 02.06.2022 – Annual General Meeting FINANCIAL YEAR 2022 12.05.2022 – Quarterly Presentation – Q1 25.08.2022 – Second quarter and Half-year Report 03.11.2022 – Quarterly Report – Q3 This information is published pursuant to the requirements set out…
Oslo, September 27th, 2021 – Observe Medical ASA (OSE: OBSRV) continues its rollout of Sippi®, and today announces that a major regional hospital in Italy has decided to implement Sippi® in the intensive care unit (ICU), with wireless connection to the hospital’s patient data management system. “The decision by a major Italian hospital to implement…
Oslo, August 20[th], 2021 – Observe Medical ASA (OSE: OBSRV) today released its financial results and presentation of the second quarter and first half-year of 2021, reporting continuous progress in the go-to-market execution for Sippi®, a unique and proprietary solution for digital, automated urine monitoring. “We have a sharp focus on continuous roll-out of Sippi®,…
Observe Medical ASA invites you to a presentation of the second quarter and first half year 2021. The presentation will take place at Felix Konferansesenter in Oslo on Friday, August 20th. The event will start at 08.30 CET and will be webcasted live on www.observemedical.com – Investor relations and at the following link: https://channel.royalcast.com/landingpage/hegnarmedia/20210820_3/ …
Oslo June 30, 2021 – Observe Medical ASA (OSE: OBSRV), today announces that it has entered into a distribution agreement and partnership with Skamex (Poland) for the launch of Sippi® in the Polish and the Romanian market. “We are pleased to announce that we are taking additional steps in the roll-out of Sippi® through our…
Observe Medical ASA has today, May 21, 2021, held the Annual General Meeting. All resolutions were made in accordance with the board's and the nomination committee's proposals. The minutes from the general meeting is attached hereto and will also be available at www.observemedical.com. Björn Larsson, CEO, Observe Medical ASA Tel.: + 46 76 620 17…
Oslo, 20 May 2021: In connection with the annual general meeting of Observe Medical ASA (the "Company") to be held on 21 May 2021 (the "AGM"), Terje Bakken, chairman of the board of directors of the Company, has as at the close of trading on the Oslo Stock Exchange on 20 May 2021, received proxies…
Oslo, May 12[th], 2021 – Observe Medical ASA (OSE: OBSRV) today released its presentation of the first quarter 2021, reporting continued advancement for the commercialization and go-to-market strategy Sippi®, a unique and proprietary solution for digital automated urine monitoring in hospitals. “We are continuing to execute on our go-to-market strategy, with current focus on the…
Observe Medical ASA invites you to a presentation of the first quarter 2021 on Wednesday May 12 at 8.30 CET. Due to the covid-19 situation the presentation will be held as a webcast only. The event will start at 08.30 CET and will be webcasted on www.observemedical.com – Investor relations and on the following link:…
Oslo May 07, 2021 – Observe Medical ASA (OSE: OBSRV), announces that Nya Karolinska Sjukhuset, Sweden, prepares new studies to broaden the clinical scope of use for Sippi® automated, digital urine measurement system, building further on the results from the recent dissertation by Dr Martin Slettengren. Following the recent dissertation by Dr. Martin Slettengren, ”Evaluation…
Oslo May 6, 2021 – Observe Medical ASA (OSE: OBSRV), announces that Sippi® automated and digital urine meter recently received new patent approvals in India, China and Brazil, further expanding and strengthening the global patent protection for Sippi® proprietary technology. “We are pleased to announce that Sippi® since end March this year, has received three…
Oslo, April 30, 2021 – Observe Medical ASA (OSE:OBSRV): The annual general meeting of Observe Medical ASA will be held on Friday, May 21, 2021 at 09:00 (CET) in the Observe Medical offices in Henrik Ibsens gate 90 (3rd floor), 0255 Oslo. The Notice of the Annual General Meeting is attached. Due to the restrictions…
Oslo, April 30, 2021 – Observe Medical ASA (OSE:OBSRV): Attached Observe Medical ASA`s annual report for 2020. The report is also available on the company's website, www.observemedical.com The annual report was reviewed and approved by the board of directors on April 29, 2021. The financial statements included in the annual report has no significant changes since…
Oslo 22 March 2021 – Observe Medical ASA (OSE: OBSRV), today announces that Observe Medical Group has received a follow-up order to deliver additional quantity of safety needles to a hospital region in the Nordic market. The follow-up order represents a value of 4.2 mSEK, with planned delivery of the products during Q3 this year.…
Oslo 8 March 2021 – Observe Medical ASA (OSE: OBSERV), today announces an order to deliver a newly introduced blood & fluid warmer system, including disposable supplies, to two university hospitals and one regional hospital in Nordic market. “This is a breakthrough order for an innovative and newly introduced blood & fluid warmer system and…
Oslo, February 23[rd], 2020 – Observe Medical ASA (OSE: OBSRV) today released its presentation of the fourth quarter 2020, reporting continued progress in terms of the commercialization and go-to-market strategy for its first product Sippi®. Sippi® is a unique and proprietary solution for digital automated urine monitoring in hospitals. “Sippi® contributes to improved clinical outcome…
Oslo February 22, 2021 – Observe Medical ASA (OSE: OBSERV), announces that Nya Karolinska Sjukhuset in Stockholm, Sweden resumes the implementation of Sippi® in clinical use at the Cardiothoracic ICU unit following a pause during 2020, due to Covid-19 As a result of the recent improvements of the Covid-19 situation at the hospital, the…
Observe Medical ASA invites you to a presentation of the fourth quarter 2020 on Tuesday February 23 at 8.30 CET. Due to the covid-19 situation the presentation will only be held as a webcast. The event will start at 08.30 CET and will be webcasted on www.observemedical.com – Investor relations and on the following link: https://channel.royalcast.com/landingpage/hegnarmedia/20210223_2/…
Oslo February 12, 2021 – Observe Medical ASA (OSE: OBSERV), announces that a major hospital in Northern Italy has equipped the ICU department with Sippi® systems in clinical use, the result of the close collaboration with Observe Medical distributor in Italy, SIM Italia. As a result of the strengthened partnership in 2020 with the distributor…
Oslo February 4, 2021 – Observe Medical ASA (OSE: OBSERV), announces strengthened presence in Norway through a partnership agreement with the Norwegian medtech agency Yallow Life Science AS and an enhanced collaboration with Norway Health Tech. Observe Medical, with headquarters in Oslo, Norway, is launching Sippi® automated digital urine meter in selected markets in Europe.…
Oslo 29 January 2021 – Observe Medical ASA (OSE: OBSERV), today announces that Observe Medical Group has received a significant order for medical consumables from a hospital region in the Nordic market. Following the recent acquisition and integration of Sylak AB, Observe Medical has delivered strong sales performance and today announces a significant order for…
Observe Medical ASA, January 15, 2021 – A doctoral (PhD) dissertation at Karolinska Institute, Stockholm, Sweden, demonstrates multiple clinical benefits of the Sippi® automated digital urine meter, and the potential paradigm shift in clinical practice of urine measurement. The PhD thesis ‘Evaluation of an automatic urinometer including use of silicone oil to decrease biofilm formation…
Observe Medical ASA, December 21, 2020: Following the acquisition by Observe Medical of Sylak AB on October 30, the team and product portfolio are now successfully integrated into Observe Medical and in full operations, with focus on the Swedish market. Observe Medical is currently launching Sippi® automated digital urine meter in selected markets in Europe,…
Oslo, November 3rd, 2020 – Observe Medical ASA (OSE: OBSERV) today released its presentation of the third quarter 2020, reporting important steps forward in terms of the commercialization and go-to-market strategy for its first product Sippi®. Sippi® is a unique and proprietary solution for digital automated urine monitoring in hospitals. “With Sippi®, Observe Medical contributes…
Observe Medical ASA invites you to a presentation of the third quarter 2020. The presentation will take place at Felix Konferansesenter in Oslo on Tuesday, November 3. The event will start at 08.30 CET and will be webcasted live on www.observemedical.com – Investor relations and on the following link: https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20201103_4 Due to COVID-19 and corresponding…
Observe Medical ASA, October 30, 2020: On October 29, 2020, Observe Medical announced the signing of the final agreement to acquire Sylak AB, a distributor of ICU/anaesthesia products in the Swedish market, for an enterprise value of SEK 6 million (on a cash and debt free basis). All conditions in the agreement is met, and…
Observe Medical ASA, October 29, 2020: Reference is made to Observe Medical’s announcement October 16, 2020 regarding the signing of a letter of intent to acquire Sylak AB, a distributor of ICU/anaesthesia products in the Swedish market, for an enterprise value of SEK 6 million (on a cash and debt free basis). Today, Observe Medical…
Observe Medical ASA, October 16, 2020: Observe Medical ASA (the "Company" or "Observe Medical") has signed a non-binding term sheet including an exclusive right to acquire 100% of the shares in Sylak AB (“Sylak”), a Swedish private limited company, for an agreed enterprise value of SEK 6 million (on a cash and debt free basis)…
Oslo, 4 September 2020: Reference is made to the stock exchange announcement by Observe Medical ASA (the "Company") on 31 August 2020 regarding the exercise of employee share options and issue of 171,875 new shares in the Company. The NOK 44,687.50 share capital increase pertaining to the exercise of the employee share options has now…
Oslo, 31 August 2020: The board of directors of Observe Medical ASA (the "Company") has resolved to increase the share capital of the Company following the completion of an exercise period for vested share options. 1. Exercise of employee share options In total 171,875 employee share options were exercised, giving the option holders the right…
Oslo, 18 August 2020 – Observe Medical ASA (OSE: OBSERV) today released its interim report for the second quarter and first half year of 2020. The company’s initial product, Sippi, a unique and proprietary solution for digital automated urine monitoring in hospitals is in an early stage of commercialization. The company confirms its market estimate…
A recently published article demonstrates that the patented Sippcoat® technology, an integrated part of Sippi® system, from Observe Medical, significantly reduces microbial biofilm formation in medical devices, suggesting a new strategy for reducing hospital-acquired infections. The article “Making medical devices safer: impact of plastic and silicone oil on microbial biofilm formation” was recently published in…
Observe Medical ASA invites you to a presentation of the second quarter and first half year of 2020 figures. The presentation will take place at Felix Konferansesenter in Oslo on Tuesday, August 18th. The event will start at 08.30 CET and will be webcasted live on www.observemedical.com – Investor relations and at the following link:…
Oslo 7 August 2020 – Observe Medical ASA (OSE: OBSERV), today announces it has entered into an updated distribution agreement and strengthened partnership with SIM Italia S.r.l. for the launch of Sippi® in the Italian market. “We are pleased to announce our strengthened partnership with SIM Italia and the signing of an updated distribution agreement…
(Oslo, 20 July 2020) Notice of exercise of employee share options In connection with the expiry date at 31 March 2020, postponed by the Board of Directors to no later than 30 September 2020, Kathrine Gamborg Andreassen, board member, have at 20 July 2020 given notice that she will exercise a total of 125,000 options…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
Reference is made to Observe Medical ASA's (the "Company") stock exchange announcement on 6 July 2020 regarding the final result in the in the rights issue of 4,090,909 new shares in the Company (the "Offer Shares") at a subscription price of NOK 11.00 per share (the "Rights Issue"). Navamedic ASA ("NAVA"), represented at the Company's…
Reference is made to Observe Medical ASA's (the "Company") stock exchange announcement on 6 July 2020 regarding the final result in the in the rights issue of 4,090,909 new shares in the Company (the "Offer Shares") at a subscription price of NOK 11.00 per share (the "Rights Issue"). Ingerø Reiten Investment Company AS ("IRIC"), represented…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
Oslo, Norway, 3 July 2020. Primary Insider and CEO, Björn Larsson, has today purchased 17,000 shares in Observe Medical ASA at an average price of NOK 13.27. Following this transaction, Björn Larsson holds 17,000 shares and 120,000 options in Observe Medical ASA. Primary insider and CFO, Per Arne Nygård, has today purchased 18,921 shares in…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
Reference is made to the ongoing rights issue of 4,090,909 new shares (the "Offer Shares") at a subscription price of NOK 11.00 per share in Observe Medical ASA (the "Company") as announced in the Company's stock exchange announcement on 19 June 2020 (the "Rights Issue"). Primary insider, Kathrine Gamborg Andreassen, a member of the Company's…
Observe Medical ASA has today, June 30, 2020, held the Annual General Meeting. All resolutions were made in accordance with the board's and the nomination committee's proposals. The minutes from the general meeting is attached hereto and will also be available at www.observemedical.com. Björn Larsson, CEO, Observe Medical ASA Tel.: + 46 76 620 17 25…
Reference is made to the ongoing rights issue of 4,090,909 new shares to a subscription price of NOK 11.00 (the "Offer Shares") in Observe Medical ASA (the "Company") as announced in the Company's stock exchange announcement on 19 June 2020 (the "Rights Issue").Ingerø Reiten Investment Company AS ("IRIC"), represented at the Company's board of directors… Observe Medical ASA – Grant of options
Observe Medical ASA: Interim report for the third quarter and 2021
Observe Medical ASA: Invitation to third quarter 2021 presentation
Observe Medical ASA: Sippi® clinical rollout accelerates, and clinical evaluations driving the health economic value of Sippi®
Observe Medical ASA (OBSRV) – Financial calendar
Observe Medical ASA: Major Italian hospital implements Sippi® wirelessly connected in the Intensive Care department
Observe Medical ASA: Interim report for the second quarter and first half-year 2021
Observe Medical ASA : Invitation to second quarter and first half year 2021 presentation
Observe Medical continues the roll-out of Sippi® – signs distribution agreement for launch in Poland and Romania
Observe Medical ASA – Annual General Meeting held
Observe Medical ASA: Disclosure of voting rights at the Annual General meeting
Observe Medical ASA: Interim report first quarter 2021
Observe Medical ASA : Invitation to first quarter 2021 presentation
Observe Medical – Nya Karolinska Sjukhuset initiates new studies to broaden the clinical scope of use for Sippi®
Observe Medical further expands and strengthens the global patent protection for Sippi® proprietary technology
Observe Medical ASA: Notice of Annual General Meeting
Observe Medical ASA – Annual report 2020
Observe Medical receives follow-up order to deliver additional quantity of safety needles to a hospital region in the Nordic market
Observe Medical: Delivering blood & fluid warmer systems to three Nordic hospitals
Observe Medical ASA: Interim report fourth quarter 2020
Observe Medical – Nya Karolinska Sjukhuset in Sweden resumes the implementation of Sippi® in clinical use at Cardiothoracic ICU unit
Observe Medical ASA : Invitation to fourth quarter 2020 presentation
Observe Medical – Sippi® installed in clinical use at ICU department at major hospital in Northern Italy
Observe Medical ASA – Strengthened presence in Norway through collaborations with Yallow Life Science AS and Norway Health Tech
Observe Medical receives significant order for medical consumables from a hospital region in the Nordic market
Observe Medical ASA – Doctoral dissertation further demonstrates clinical benefits of Sippi®
Observe Medical ASA – Enhanced Nordic sales team in full operations, driving Sippi® clinical use in the Nordics, following the recent acquisition of Sylak AB
Observe Medical ASA: Interim report third quarter 2020
Observe Medical ASA : Invitation to third quarter 2020 presentation
Observe Medical ASA – Closing of the transaction to acquire Sylak AB completed.
Observe Medical ASA – Final agreement to acquire Sylak AB signed
Observe Medical ASA – Signs agreement with the intention to acquire Sylak AB
Observe Medical ASA: Registration of share capital increase following exercise of employee share options
Observe Medical ASA: Exercise of share options, resolution to increase the share capital and mandatory notification of trade
Observe Medical ASA: Interim report second quarter and first half year 2020
Observe Medical: Scientific article provides evidence of Sippi® technology reducing microbial biofilm formation – a risk factor for patient infection
Observe Medical ASA : Invitation to second quarter and first half year of 2020 presentation
Observe Medical signs updated distribution agreement for Sippi® in Italy
Observe Medical ASA: Mandatory notification of trades by primary insider
Observe Medical ASA – Registration of share capital increase
Observe Medical ASA – Primary insider notice
Observe Medical ASA – Major shareholding notification and primary insider notice
Observe Medical ASA – Final result of the Rights Issue
Observe Medical ASA – Preliminary results of the Rights Issue
Observe Medical ASA: Primary Insider notification
Observe Medical ASA – The subscription period for the rights issue expires today
Observe Medical ASA – Last day of trading in subscription rights
Observe Medical ASA – Primary insider notice
Observe Medical ASA: Annual General Meeting held
Observe Medical ASA – Primary insider notice